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Abstract
Background: Actinobacillus pleuropneumoniae, a Gram-negative bacterium, is the causative agent of porcine
pleuropneumonia, a highly contagious and often fatal disease. Because current vaccines confer limited protection
against A. pleuropneumoniae infection, the development of more effective vaccines is urgently required. The
identification of immunogenic and protective antigens, such as an outer-membrane lipoprotein, will advance this
purpose.
Results: Sixty putative lipoproteins were predicted from the genomic sequence of A. pleuropneumoniae using
multiple algorithms. Here, we focused on the characteristics of the putative lipoprotein Lip40 from A. pleuropneumoniae
strain SLW01 (serovar 1). Lip40 shares sequence similarity with many bacterial lipoproteins, and the structural prediction
of Lip40 suggests that it is similar to A. pleuropneumoniae TbpB. The N-terminus of Lip40 contains an interesting
tandemly repeated sequence, Q(E/D/P)QPK. Real-time RT–PCR indicated that the expression of lip40 was significantly
upregulated at 42 °C, at 16 °C, and under anaerobic conditions. Recombinant Lip40 (rLip40) produced in Escherichia coli
BL21(DE3) was specifically recognized by porcine convalescent serum directed against A. pleuropneumoniae. Lip40 was
confirmed to localize at the bacterial outer membrane, and its expression was significantly stimulated when A.
pleuropneumoniae was cultured under various stress conditions. Lip40 also protected 75 % of mice from fatal
virulent A. pleuropneumoniae infection.
Conclusions: The immunogenic outer-membrane protein Lip40 is stress responsive, protects mice against
infection, and might be a virulence determinant. Further investigation of Lip40 should expedite vaccine
development and provide insight into the pathogenesis of A. pleuropneumoniae.
Background
Actinobacillus pleuropneumoniae is the etiological agent
of porcine pleuropneumonia, a severe and often fatal re-
spiratory disease of swine, which is associated with sig-
nificant economic losses in industrialized pig production
worldwide [1]. To date, 16 serovars of A. pleuropneumo-
niae have been identified [2]. The pathogenesis of A.
pleuropneumoniae infection is associated with several
virulence factors, including but not limited to exotoxins.
Other factors, such as capsular polysaccharides, lipo-
polysaccharides, adhesins, proteases, outer-membrane
proteins, and transcriptional regulators, are also reported
to be involved in its pathogenesis [3–6].
Bacterial lipoproteins are a set of membrane-associated
proteins characterized by a conserved lipid-modified cyst-
eine, which play important roles in bacterial physiological
processes [7]. The involvement of lipoproteins in the in-
fection processes of many pathogens has received wide at-
tention [8]. Lipoproteins play a key role in the bacterium’s
adhesion to the host cell, are involved in antibiotic resist-
ance, and regulate the host immune response [8]. They
have been reported to be pathogen-associated molecular
patterns, which are recognized and captured by Toll-like
receptors or other pattern-recognition receptors, inducing
the activation of the immune cells and initiating the in-
flammatory processes [9]. Many immunogenic bacterial li-
poproteins have been developed as candidate vaccines [8].
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A putative lipoprotein, Lip40, containing the tandemly
repeated sequence Q(E/D/P)QPK was observed among
the 60 putative lipoproteins predicted from the pub-
lished genomic sequence of A. pleuropneumoniae strain
JL03. The lip40 gene from an A. pleuropneumoniae field
isolate, SLW01 (serovar 1), was cloned and character-
ized, including its sequence features, predicted structure,
immunogenicity, subcellular localization, expression
after stimulation, and protective efficiency in mice, ex-
tending our understanding of this lipoprotein.
Methods
Bacterial strains, plasmids, primers, and growth
conditions
The bacterial strains, plasmids, and primers used in
this work are listed in Table 1. The primers used in
this study were synthesized by Sangon Biotech (Shang-
hai, China). Escherichia coli strains were cultured in
Luria–Bertani broth, supplemented with the appropri-
ate antibiotic (50 μg/ml ampicillin). Actinobacillus
pleuropneumoniae strains were cultured in tryptic soy
broth (TSB) or on tryptic soy agar (TSA) (Becton,
Dickinson & Company, Franklin Lakes, New Jersey,
USA), supplemented with 10 μg/ml nicotinamide ad-
enine dinucleotide (Sigma-Aldrich Co., Ltd, St. Louis,
Missouri, USA). For the anaerobic treatment, A.
pleuropneumoniae was cultured under oxygen-free
conditions (85 % N2, 10 % H2, and 5 % CO2) (Forma
Anaerobic System, Thermo Fisher Scientific, Marietta,
USA).
Prediction of A. pleuropneumoniae lipoproteins
The previously sequenced and annotated A. pleuropneu-
moniae strain JL03 was selected to identify the lipopro-
teins of A. pleuropneumoniae [10]. The programs used
for lipoprotein prediction were: (i) ScanProsite (http://
prosite.expasy.org/) [11]; (ii) DOLOP (http://www.mrc-
lmb.cam.ac.uk/genomes/dolop/) [12]; (iii) SignalP 4.1
(http://www.cbs.dtu.dk/services/SignalP/) [13]; (iv) Pre-
diSi (http://www.predisi.de/) [14]; (v) Phobius (http://
phobius.binf.ku.dk/) [15]; and (vi) LipoP 1.0 (http://
www.cbs.dtu.dk/services/LipoP/) [16]. Possible lipopro-
teins were then subjected to a ‘majority vote’ selection
procedure to exclude any false positive lipoproteins [17].
Table 1 Strains, plasmids, and primers used in this study
Strain, plasmid and primer Relevant characteristics Source
A. pleuropneumoniae
SLW01 Serovar 1 Weicheng Bei
13039 Serovar 10 Pat Blackall
E. coli
DH5a Cloning vehicle: supE44 ΔlacU169 (φ80 lacZΔM15) hsdR17recA1 endA1 gyrA96 thi-1 relA1 Takara (Dalian, China)
BL21(DE3) Expression host: F− ompT r−B m
−




pMD18-T E. coli cloning vector carrying an ampicillin resistance determinant Takara (Dalian, China)
pMD-lip40 pMD18-T carrying lip40 gene of A. pleuropneumoniae strain SLW01. This work
pGEX-KG N-terminal glutathione S-transferase (GST) fusion expression vector: pBR322 ori, Ampr [19]
pGEX-lip40 pGEX-KG carrying the lip40 gene for over-expression Lip40 protein This work
Primers (Primers were all synthesized in Sangon, Shanghai, China)
P1 5′ ATG AAA AAC ATC ACA AAA TTT GCA G 3′, upstream primer for lip40 gene cloning This work
P2 5′ TTA CTT TTG TTG TTT TGC GCC AAA 3′, downstream primer for lip40 gene cloning This work
P3 5′ CGG TTC GAT TTG GTG TGT ATG A 3′,upstream primer of lip40 gene for qRT-PCR analysis This work
P4 5′ AAC AAG TAA GCA TCA CCT GTG T 3′, downstream primer of lip40 gene for qRT-PCR analysis This work
P5 5′ AAG TGG CAG AGC TGG AAG AT 3′, upstream primer of internal control gene rluC for qRT-PCR
analysis
This work
P6 5′ TCA CAC CAA AAC TCA AGC CG 3′, downstream primer of internal control gene rluC for qRT-
PCR analysis
This work
P7 5′ TTG GAT CCT GTG GCA GTA AGA ACC ATT C 3′, upstream primer with BamHI site (underlined)
comprising positions 58 to 77 of lip40 coding sequence
This work
P8 5′ GGA AGC TTT TAC TTT TGT TGT TTT GCG C 3′, downstream primer with HindIII site (underlined)
comprising positions 878 to 897 of lip40 coding sequence
This work
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Cloning and bioinformatic analysis of Lip40 protein
The genomic DNA was isolated from A. pleuropneumo-
niae SLW01 as described previously [18]. Specific
primers for the lip40 gene were designed according to
the conserved features of the lip40 sequence in the
complete A. pleuropneumoniae genome. The lip40 gene
was cloned by PCR, and the product was inserted into
pMD18-T (Takara, Dalian, China), generating the plas-
mid pMD-lip40. The fragment inserted into pMD-lip40
was sequenced in both directions. The sequence features
were analyzed with LipoP 1.0. A multiple sequence
alignment was constructed with BioEdit (version 7.0).
The structure of Lip40 was predicted by with the
SWISS-model method (http://swissmodel.expasy.org/),
and the Lip40 protein was superimposed onto the N
lobe and C lobe of TbpB (Protein Data Bank [PDB]:
3HOL) with WinCoot.
Reverse transcription–real-time quantitative PCR (RT–
qPCR)
Total RNA was extracted from an A. pleuropneumoniae
culture with the RNeasy Mini kit (Qiagen, Shanghai,
China), treated with DNase I (Invitrogen, CA, USA), and
reverse-transcribed into cDNA with the Omniscript® RT
Kit (Qiagen), according to the manufacturer’s protocol.
The mRNA levels of A. pleuropneumoniae cultured
under different conditions were measured with a SYBR
Green-based method. The rluC gene was used as the in-
ternal control. qPCR was performed in a 20 μl reaction
volume containing 10 μl of 2 × SYBR Green Realtime
PCR Master Mix (Toyobo, Osaka, Japan), 1 μl of cDNA,
0.5 μl each of the forward and reverse primers (10 μmol/l),
and 8 μl of dH2O. An ABI 7500 Sequence Detection
System was used for the amplification reactions, and
qPCR was performed in triplicate. The 2–ΔΔCt method
was used to calculate the relative expression of the
lip40 gene.
Expression and purification of Lip40 from E. coli
The mature protein-coding sequence of Lip40 was
cloned from the A. pleuropneumoniae genomic DNA
using primers P7 and P8 (Table 1). The PCR products
were then digested with BamHI/HindIII and ligated
into the prokaryotic expression vector pGEX-KG [19],
generating the recombinant plasmid pGEX-lip40. Re-
combinant Lip40 (rLip40) was then expressed from
pGEX-lip40 in E. coli BL21(DE3). rLip40 was col-
lected from the E. coli lysate and purified with a
glutathione (GST)–Sepharose 4B column (Amersham
Biosciences, Buckinghamshire, England). The immu-
noreactivity of the purified rLip40 was verified with
western blotting, using porcine convalescent serum
directed against A. pleuropneumoniae as the primary
antibody.
Production of polyclonal antibodies against rLip40
Two female New Zealand white rabbits (~2.5 kg; pur-
chased from the Centre for Disease Control and Preven-
tion [CDC] of Hubei Province, China) were used to
produce polyclonal antibodies directed against rLip40.
All the animal experiments in the present study were ap-
proved by the Animal Experiment Committee of Central
China Normal University. Each rabbit was first injected
intradermally with purified rLip40 (650 μg). The purified
protein (0.5 ml) was emulsified with an equal volume of
Freund’s complete adjuvant (Sigma-Aldrich, USA). Ani-
mals were subsequently injected three times, at 15-day
intervals, with the same immunogen emulsified with in-
complete Freund’s adjuvant with the same regimen.
Antisera were collected 10 days after the third booster
immunization.
The titers and specificity of the polyclonal antibodies
were evaluated with a Lip40 enzyme-linked immuno-
sorbent assay (ELISA). Briefly, flat-bottomed 96-well
polystyrene ELISA plates (Haimen Shengbang, Haimen,
China) were coated with 0.17 μg of purified rLip40
diluted in 100 μl of coating buffer (50 mM sodium car-
bonate, pH 9.6). The coated plates were washed three
times with phosphate-buffered saline (PBS) plus 0.05 %
Tween 20 (PBST), blocked at 37 °C for 1 h with blocking
buffer (5 % skimmed milk in PBST), and then washed
three times with PBST. For the ELISA, 2 μl samples and
198 μl of PBST were added to each well in the first line
of wells in the plate and 100 μl of PBST was added to
the rest of the wells. The samples were diluted and incu-
bated at 37 °C for 40 min. After four washes with PBST,
100 μl of horseradish peroxidase (HRP)-conjugated sec-
ondary antibody (Southern Biotechnology Associates,
Birmingham, USA), diluted 1:5000 in PBST, was added
to each well, and the plates were incubated at 37 °C for
30 min. After five washes, 100 μl of 3,3′,5,5′-tetra-
methylbenzidine color development solution (Biotime
Biotech, Haimen, China) was added to each well. The
plates were incubated at room temperature in the dark
for approximately 10 min, and the catalytic reaction was
then stopped with 50 μl of 1 % SDS. The optical density
was read at 630 nm (OD630) in an ELISA reader (Power-
Wave XS, Bio-Tek, Winooski, USA).
Subcellular localization of Lip40
The subcellular fractionation of A. pleuropneumoniae
was performed as described previously [20]. In brief, 1 l
of bacterial culture was pelleted and resuspended in
10 ml of solution A (0.2 M Tris–HCl [pH 8.0], 1 M su-
crose, 1 mM EDTA). Lysozyme was then added to the
cell suspension to a final concentration of 1 mg/ml, vor-
texed, and incubated at room temperature for 5 min.
dH2O (40 ml) was added to the swirling mixture before
it was placed on ice. The cells were centrifuged at
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200,000 × g for 45 min at 4 °C. The supernatant contained
the periplasmic fraction. The pellet was resuspended in
7.5 ml of ice-cold solution B (10 mM Tris–HCl [pH 7.5],
5 mM EDTA, 0.2 mM DTT), supplemented with 50 μl of
DNase (1 mg/ml). The cells were broken by two passes at
108 Pa. The unbroken cells were pelleted by centrifugation
at 4000 × g for 10 min at 4 °C. The supernatant was then
centrifuged at 280,000 × g for 4 h at 4 °C. The supernatant
contained the cytoplasmic fraction and the pellet con-
tained the crude membranes, which were collected separ-
ately. The crude membrane pellet was resuspended in
9 ml of solution C (50 mM Tris–HCl [pH 8.0], 2 % [v/v]
Triton X-100, 10 mM MgCl2), and centrifuged at
85,000 × g for 30 min at 4 °C. The supernatant contained
the cytoplasmic membrane fraction. The pellet, containing
the outer membrane, was washed in 1 ml of solution C,
centrifuged at 85,000 × g for 20 min at 4 °C, washed three
times with 500 μl of dH2O, and stored at −20 °C. The
extracellular proteins were precipitated from the filtered
culture supernatant with trichloroacetic acid at 4 °C over-
night, followed by centrifugation (17,700 × g, 1 h, 4 °C),
and were washed six times with 1 ml of 96 % ethanol. The
pellet was dried and redissolved in 400 μl of solution D
(7 M urea, 2 M thiourea, 4 % CHAPS [w/v], 30 mM Tris–
HCl, [pH 8.0]), and stored at −20 °C. The subcellular
localization of the Lip40 protein was determined with
western blotting using rabbit hyperimmune anti-rLip40
serum (1:400) as the primary antibody.
Expression of Lip40 protein under stress conditions
Actinobacillus pleuropneumoniae, cultured in TSB under
normal conditions (aerobically at 37 °C) for 3 h, was di-
vided into four equal parts and incubated under anaer-
obic condition, or at 42 °C, 16 °C, 37 °C for another 3 h,
respectively . The cells were harvested by centrifugation,
and the outer-membrane fractions were extracted as de-
scribed above. The concentration of all outer-membrane
samples prepared under different culture conditions
were determined with a BCA protein assay kit (GenStar
BioSolutions, Beijing, China). Equal volumes of the sam-
ples (66 μg) were separated with 12 % sodium dodecyl
sulfate polyacrylamide gel electrophoresis and trans-
ferred to a nitrocellulose membrane. Western blotting
was performed with rabbit hyperimmune anti-rLip40
serum (1:400) as the primary antibody. The expression
of Lip40 was determined in triplicate. The expression
levels of Lip40 in the outer-membrane samples were de-
termined according to the density of the bands, with the
Quantity One software.
Vaccination and challenge of mice
The protective efficacy of rLip40 was tested in a mouse
vaccination/challenge model. Forty-eight 6-week-old
specific-pathogen-free BALB/c mice (CDC, Hubei
Province, China) were randomly allocated to four groups
of 12 animals. ApxI toxin was obtained from the super-
natant of A. pleuropneumoniae strain 13039 (serovar 10)
cultures, as described previously [21], and inactivated
with 0.4 % formaldehyde. Group 1 was inoculated with
PBS and used as the negative control; group 2 was vacci-
nated with 150 μg of rLip40; group 3 was vaccinated
with 150 μg of inactivated ApxI; and group 4 was vacci-
nated with a commercial trivalent inactivated vaccine
(containing serovars 1, 2, and 7; purchased from Wuhan
Keqian Biotech, China). For groups 2 and 3, the antigens
were emulsified separately with complete Freund’s adju-
vant for the first immunization, and with incomplete
Freund’s adjuvant for the booster immunization. Serum
samples were collected before each immunization and
before the mice were challenged, and assayed with the
Lip40-ELISA, as described above, and an ApxI-ELISA,
as described previously [22]. Each group was intraperito-
neally challenged with 2.5 × 106 colony-forming units of
log-phase A. pleuropneumoniae SLW01 14 days after the
second vaccination. The numbers of surviving mice were
recorded every day for 5 days after the challenge.
Results
Sixty putative A. pleuropneumoniae lipoproteins
With the ‘majority vote’ approach [17], 60 of the 89
identified putative lipoproteins from A. pleuropneumo-
niae JL03 were predicted as lipoproteins, including
some previously reported lipoproteins, such as TbpB
(gene locus APJL_0250) [23] and PalA (gene locus
APJL_0317) [24], as well as several previously reported
putative lipoproteins [25], indicating that our prediction
method and results are reliable. The sequence characteris-
tics of the 60 lipoproteins are listed in Additional file 1:
Table S1. Putative lipoprotein Lip40, containing a special
N-terminal tandemly repeated sequence, was further in-
vestigated in the present study.
Lip40 has a conserved lipoprotein domain
The lip40 gene from A. pleuropneumoniae SLW01 was
cloned and sequenced (GenBank accession number:
KP119767). The Lip40 protein was predicted to have the
typical characteristics of lipoproteins with the LipoP 1.0
program, and contains the recognition sequence for signal
peptidase II (LVITA↓CGSKN). The lipid modification site
of Lip40 was predicted to be located at Cys20. A multiple
sequence alignment of Lip40 and lipoproteins from Aggre-
gatibacter actinomycetemcomitans and Cardiobacterium
hominis showed that Lip40 is homologous to those lipo-
proteins (similarity > 33 %; Additional file 2: Figure S1). It
also displayed similarity with several transferrin-binding
proteins (Tbps) from pathogenic bacteria (similarity >
34 %; Additional file 3: Figure S2). The multiple sequence
alignment showed that Lip40 is homologous to both the
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N- and C-lobes of A. pleuropneumoniae TbpB (Fig. 1a).
Structural prediction revealed that the Lip40 protein con-
sists of an eight-stranded β barrel accompanied by a do-
main made up of four β strands (Fig. 1b). Superimposition
of Lip40 onto the C lobe and N lobe of TbpB (PDB:
3HOL) indicated that they have high structural similarity
(Fig. 1c and d). We also noted that Lip40 contains a tan-
demly repeated sequence, Q(E/D/P)QPK, at its N-
terminus. Actinobacillus pleuropneumoniae strain SLW01
Lip40 has nine tandem repeats. The numbers of repeats in
the Lip40 homologues from other A. pleuropneumoniae
strains were also calculated, and according to the available
genome sequences of these strains, the repeat numbers
differ among the different strains (8–27) (Table 2).
Transcription of lip40 is stimulated by stress
The expression of the lip40 gene was analyzed under in
vitro growth conditions mimicking the environment
during infection, including anaerobic conditions and
high temperature (42 °C). The expression of lip40 at low
temperature (16 °C) was also evaluated. As shown in
Fig. 2, the transcription of the lip40 gene was signifi-
cantly upregulated under stress relative to its transcrip-
tion under normal culture conditions (37 °C, aerobic),
and heat shock most strongly increased lip40 expression
(45-fold). These results indicate that lip40 is responsive
to temperature and anaerobic stress, and might be in-
volved in the bacterial infection process.
rLip40 is immunoreactive
To express the Lip40 protein, the lip40 gene without the
signal peptide was cloned from A. pleuropneumoniae
SLW01, restricted, and ligated into the prokaryotic
expression plasmid pGEX-KG. Escherichia coli cells con-
taining pGEX-lip40 were induced with isopropyl-β-D-
thiogalactopyranoside. The recombinant Lip40 protein
Fig. 1 Sequence alignment and structural prediction of Lip40. a Sequence alignment of A. pleuropneumoniae Lip40 and the N- and C-lobes of A.
pleuropneumoniae TbpB (PDB: 3HOL). b Overall structure of Lip40 protein (blue). The structure consists of an eight-stranded β barrel accompanied
by a domain made up of four β strands. c Superimposition of Lip40 onto the TbpB N lobe (orange). d Superimposition of Lip40 onto the TbpB C
lobe (pink)
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was confirmed to be present in the soluble supernatant of
the cell lysate with SDS-PAGE, as shown in Fig. 3a. The
purification of rLip40 is shown in Fig. 3b. Western blot-
ting revealed a band with a molecular weight of ~56 kDa
for rLip40, whereas no signal was detectable for GST
(Fig. 3c). This result confirms that porcine convalescent
serum directed against A. pleuropneumoniae recognized
and bound specifically to the rLip40 protein.
Lip40 elicits a strong humoral immune response in
rabbits
Rabbits were immunized with four doses of purified
rLip40 by intradermal injection. Serum samples were
collected before each immunization and before euthan-
asia and the antibodies against rLip40 were tested with
an ELISA, to verify the generation of a Lip40-specific
immune response in rabbits. Lip40-specific antibodies
appeared two weeks after the first immunization, and
then increased quickly after the second and third in-
jections (Additional file 4: Figure S3A). At the end of
the immunization regimen, titration of the rabbit sera
(at 55 days) showed the highest reactivity, with an
increase of up to 2 × 105-fold (Additional file 4: Figure
S3B), suggesting that rLip40 stimulates a strong anti-
body response in rabbits. The same amount of puri-
fied GST was used to coat 96-well plates, and
antibody directed against GST was evaluated with a
GST-ELISA, as described for the Lip40-ELISA. The
GST-specific IgG titer in the hyperimmune serum
was only 1:3200 (Additional file 4: Figure S3B), much
lower than that of the Lip40-specific antibody. There-
fore, it appears that Lip40 played a major role in the
elicitation of rabbit antibodies directed against the
GST–Lip40 fusion protein.
Lip40 is located in the outer membrane
Although bioinformatic analysis showed that Lip40 is lo-
cated on the outer membrane, experimental verification
Table 2 Numbers of tandem repeats in different A. pleuropneumoniae strains
Strain Serovar Protein ID No. of total
amino acid
Tandem repeats
No. of start position No. of end position No. of repeats
SLW01 1 AKJ32477 298 38 82 9
4074 1 ZP_00134150.1 383 38 167 26
JL03 3 YP_001652178.1 378 38 162 25
M62 4 ZP_07532361.1 372 52 156 21
L20 5b YP_001053852.1 293 38 77 8
Femo 6 ZP_07336294.1 368 38 152 23
AP76 7 YP_001969011.1 388 37 172 27
N273 13 ZP_07545435.1 397 52 181 26
Fig. 2 Transcription changes in the A. pleuropneumoniae lip40 gene
under different conditions. Relative expression of the lip40 gene
during stimulation with 42 °C, anaerobic conditions, or 16 °C was
normalized to that of lip40 expressed under normal culture conditions.
The fold changes in lip40 expression are shown. Error bars indicate
standard errors. Double asterisks indicate P < 0.01, calculated with
Student’s t test
Fig. 3 Expression (a), purification (b), and western blotting analysis
(c) of rLip40 protein. Protein samples were separated with 12 %
SDS-PAGE and blotted onto nitrocellulose membrane. The membrane
was sequentially incubated with porcine convalescent serum directed
against A. pleuropneumoniae and HRP-labeled goat anti-porcine
IgG secondary antibody, and the color was developed with a
3,3′-diaminobenzidine (DAB) peroxidase substrate (Tiangen, Beijing,
China). M, prestained protein ladder (Fermentas, Vilnius,
Lithuania); lane 1, GST; lane 2, rLip40
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was required (data not shown). Subcellular fractions of
A. pleuropneumoniae cells were extracted carefully, in-
cluding the cytoplasmic proteins, periplasmic proteins,
cytoplasmic membrane proteins, outer-membrane pro-
teins (OM), and extracellular proteins (Fig. 4a). A band
corresponding to Lip40 (~30 kDa) was observed in the
outer-membrane fraction with western blotting, as
shown in Fig. 4b. No Lip40 signal was observed in the
other subcellular fractions. Our results confirm that
Lip40 localizes to the outer bacterial membrane.
Enhanced expression of Lip40 protein under stress
To test whether the expression of Lip40 protein in the
outer-membrane fraction is stimulated by stress condi-
tions, A. pleuropneumoniae cells cultured under anaer-
obic condition or high and low temperatures were
collected, and their outer-membrane fractions were ex-
tracted and quantified. Equal amounts of samples
(66 μg) were separated by SDS-PAGE, and the expres-
sion levels were determined with western blotting
(Fig. 5). In general, the expression of Lip40 protein was
enhanced under stress conditions, especially at 42 °C,
and the Lip40 signal increased more than three-fold
under heat shock. These results indicate that both the
transcription of the lip40 gene and the translation of the
Lip40 protein increased in response to stress. Therefore,
Lip40 may be involved in the adaptation of A. pleurop-
neumoniae to environmental changes.
Lip40 is protective in mice
Serum samples from mice immunized with different an-
tigens were analyzed with ELISAs (Fig. 6). All the mice
were negative for rLip40 and ApxI before immunization.
Serum samples from the mice inoculated with PBS
(group 1) or ApxI (group 3) showed no detectable anti-
body against Lip40 during this study (Fig. 6a), whereas
the sera from group 2, vaccinated with rLip40, were
positive for Lip40 antibodies 14 days after the first
vaccination, and the titer had increased by the second
vaccination. The Lip40 antibody titers in group 2
were significantly higher than those in the other
groups (P <0.01, Student’s t test; Fig. 6a). The mice in
groups 1 and 2 were also free of ApxI antibodies, but
the mice in group 3 showed a significantly stronger ApxI
antibody response than the other groups (P < 0.01). As
shown in Fig. 6b, group 4, vaccinated with commercial
vaccine, also showed a strong ApxI antibody response
after vaccination. The mice were challenged with virulent
A. pleuropneumoniae SLW01 14 days after the second
immunization, and the survival rates were recorded for
5 days after challenge (Fig. 7). No mice inoculated with
PBS survived the challenge, and the protective efficacies of
rLip40, ApxI, and commercial vaccine were 75 % (9/12),
100 % (12/12), and 91.7 % (11/12), respectively. These
results show that rLip40 protected more than half the ani-
mals (75 %) from the challenge. Thus, the protective effi-
cacy of rLip40 was significantly higher than that of the
negative control (0 %), indicating that rLip40 is immuno-
protective and provides effective protection against A.
pleuropneumoniae infection in mice.
Discussion
Lipoproteins are required for the virulence of some
pathogenic bacteria. They play a variety of roles in host–
Fig. 4 Subcellular localization of Lip40. a SDS-PAGE analysis of A. pleuropneumoniae subcellular fractions. b Western blotting analysis. Subcellular
fractions were separated with 12 % SDS-PAGE, blotted onto nitrocellulose membranes, and incubated with rabbit anti-rLip40 polyclonal antibody.
Color was developed with a DAB peroxidase substrate (Tiangen). M, prestained protein ladder; lane 1, cytoplasmic proteins (CP); lane 2, periplasmic
proteins (PP); lane 3, cytoplasmic membrane proteins (CM); lane 4, outer-membrane proteins (OM); lane 5, extracellular proteins (EP). The nitrocellulose
membranes displayed a band with a molecular weight of ~30 kDa in the outer-membrane fraction, indicating that Lip40 is located on
the outer membrane. No signal was detected in the other subcellular fractions
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pathogen interactions, from surface adhesion and the
initiation of inflammatory processes to the translocation
of virulence factors into the host cytoplasm [8]. How-
ever, the pathogenesis of A. pleuropneumoniae lipopro-
teins has rarely been examined. Most such studies have
focused on their immunogenicity and vaccine potential,
including studies of TbpB [26–28] and OmlA [29, 30].
These proteins were shown to be immunoprotective and
important vaccine components (PleuroStar APP, Novartis
Animal Health Inc., Switzerland). However, PalA was
reported to inhibit the protective efficacy of ApxI and
ApxII [24].
In the present study, a putative lipoprotein, Lip40,
which contains an interesting tandemly repeated se-
quence, Q(E/D/P)QPK, was characterized. Previous
studies have demonstrated the relationship between cod-
ing tandem repeat (CTR) sequences and virulence in
Chlamydia pecorum [31, 32]. CTRs at the incA locus en-
code a variable number of repeated motifs, and the
number of repetitions in incA is related to the virulence
of C. pecorum strains [32]. Similarly, the number of tan-
dem repeats in Lip40 varies within its homologues in
different serovars of A. pleuropneumoniae strains.
Therefore, the possible role of Lip40 in bacterial patho-
genesis requires further characterization.
Oxygen deprivation and high temperature are two
common stresses that A. pleuropneumoniae encounters
during infection [5, 33]. Transcriptional profiles under
anaerobic conditions [33] and acute disease [34] have
been analyzed with microarray chips to discover poten-
tial virulence factors, which are usually considered to be
upregulated under in vivo conditions or in a mimicked
infection. This genome-wide transcriptional screening of
the differentially expressed genes of A. pleuropneumo-
niae revealed no Lip40 homologue. In this study, we
confirmed that Lip40 is upregulated at both the tran-
scriptional and translational levels by stress. The mecha-
nisms involved in the adaptive responses of A.
Fig. 5 Expression changes of Lip40 protein in the outer-membrane fraction. a SDS-PAGE. Actinobacillus pleuropneumoniae outer-membrane
samples were extracted from cells after they were treated with heating, anaerobic conditions, or cold stimulation, or with normal conditions. Equal
amounts (66 μg) of outer-membrane proteins were analyzed with SDS-PAGE. b Western blotting analysis. The procedures were as described above. M,
prestained protein ladder; lane 1, high temperature (42 °C); lane 2, anaerobic conditions; lane 3, low temperature (16 °C); lane 4, normal conditions
(37 °C). c Intensity of the bands was quantified with the Quantity One software. Relative expression levels were obtained by normalizing the intensity
of stress-treated samples to that of untreated samples in each assay. Double asterisks (**) indicate a significant difference (P < 0.01) compared with the
stress-treated samples (Student’s t test)
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Fig. 6 Humoral responses in mice. Antibodies against rLip40 (a) and ApxI (b) were evaluated at different time points with ELISAs. ELISA titers are
expressed as the logarithm (log10) of the reciprocal of the highest dilution of serum with an OD630 value above that of the cutoff value for each
mouse. Double asterisks (**) indicate P < 0.01, calculated with Student’s t test
Fig. 7 Protection conferred by different antigens against A. pleuropneumoniae challenge in mice (survival rates). Numbers of surviving mice in
each group was monitored for 5 days after challenge. Numbers of surviving mice did not change 72 h after infection
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pleuropneumoniae remain to be investigated. The effects
of cold shock were tested as a typical environmental
stress. Reports have suggested that the autumn–winter
transition is one of the outbreak peaks of porcine
pleuropneumonia in China [35], and the environmental
temperature is always far lower than the normal growth
temperature for mesophilic bacteria during this period.
It is possible that the adaptation of A. pleuropneumoniae
to cold stress is responsible for the infections observed
at this time of year. Our results indicate that both the
transcriptional and translational levels of Lip40 were ele-
vated at 16 °C compared with those at 37 °C, suggesting
that Lip40 is a factor in the responsiveness of A. pleur-
opneumoniae to low temperature. Therefore, we
hypothesize that Lip40 is a potential virulence factor and
involved in pathogen–environment and/or pathogen–
host interactions.
Commercial vaccines, including whole-cell bacterins
and second-generation subunit vaccines, only confer
partial protection against A. pleuropneumoniae infection
[29]. Therefore, it is essential that more effective vac-
cines be developed. The identification of conserved im-
munogenic antigens, especially outer-membrane-located
proteins, will advance this purpose. Several outer-
membrane-associated proteins have been verified separ-
ately as vaccine components or candidate vaccines with
various investigation methods, including TbpB, OmlA,
OmpP2, OmpA, and OmpW [25, 36, 37]. In addition to
their location on the outer bacterial membrane, many li-
poproteins of Gram-negative bacteria are considered to
be efficient candidate vaccines [38]. The putative outer-
membrane proteins and lipoproteins have been identi-
fied in the genome of Pasteurella multocida, a great step
forward in the development of a protective vaccine
against fowl cholera [39, 40]. Similar research was
undertaken in A. pleuropneumoniae, and several lipopro-
teins were cloned and their protective efficacies were in-
vestigated [25]. Here, we report a putative lipoprotein,
Lip40, confirmed to be an outer-membrane-localized
stress-responsive factor. Purified rLip40 induced strong
antibody responses when it was administered to rabbits.
Mice vaccinated with rLip40 displayed a survival rate of
75 %, which was significantly higher than that of the nega-
tive control group (0 %), indicating that rLip40 can be used
as a component of vaccine against A. pleuropneumoniae
infection. Our results provide additional confirmation of
the importance of bacterial outer-membrane lipoproteins
in vaccine development.
Conclusions
A putative lipoprotein, Lip40, from A. pleuropneumoniae
was characterized and confirmed to be both immuno-
genic and localized to the outer membrane. Its expres-
sion is responsive to temperature and anaerobic stimuli.
Lip40 was also shown to be a potential protective anti-
gen for vaccine development. Further investigation of
the roles of Lip40 in A. pleuropneumoniae infection
should provide insight into the pathogenesis of this
bacterium.
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